Ansh Labs' Activin A and Follistatin Like-3 ELISA kits used in a ground-breaking study on preeclampsia and peripartum cardiomyopathy, "Placental senescence pathophysiology is shared between peripartum cardiomyopathy and preeclampsia in mouse and human"
https://t.co/3pWuHG1Pou
New: Intact and Total Gastric Inhibitory Polypeptide (GIP) Assays from AnshLabs:
Intact GIP ELISA (AL-1022) and Total GIP ELISA (AL-1013)
Intact measures 1-42 and 3-42 and Total measures 1-30, 1-42, and 3-42.
To learn more, click here: https://t.co/M41FvVtLX9
New Rat/Mouse IGFBP-4 immunoassay (AL-1025) with a 10 uL sample size, 0.07 ng/mL sensitivity, analytical range of 0.56 to 18 ng/mL, same day turn-around time. Does not detect mouse or rat IGF-I, IGF-II, IGFBP-2/3/5. Rat and Mouse expected values provided. https://t.co/u3tcBbu9FG
The Ansh Labs’ Canine AMH ELISA kit has become the method of choice for leading companion animal testing centers.
Learn More at: https://t.co/yfmQTpHkVu
#spay#neuter#cryptorchidism#veterinary
Exciting news! Ansh Labs is making our best antibodies available to help researchers make new discoveries. These antibodies are highly specific and have been validated in a variety of applications.
#antibodies#biomarkers#translationalresearch#antibody
https://t.co/wubJlex5CK
Recently, an Ultra-Sensitive Inhibin B assay has been developed to detect to 1.5 pg/mL. With this, men with positive TESE had more than 2x the Inhibin B levels (median 5.03 pg/mL [1.93-8.5] vs. 2.19 pg/mL [0.2-4.72], p=0.006).
For our friends, family and clients who celebrate the Moon Festival, Happy Mid-Autumn Festival! We wish you a safe and warm celebration with your loved ones.
#midautumnfestival#moonfestival
Ansh Labs’ FDA-cleared Glucagon ELISA kit is rapidly becoming the assay of choice for both clinical and research laboratories worldwide. Read more:
https://t.co/NnPq6ny203
#Glucagon#ELISA#Immunoassay
Today marks Malaysia’s 64th Independence Day, where Malaysians around the world commemorate the Malayan Declaration of Independence in 1957.
Warm wishes to all Malaysians, and Selamat Hari Merdeka (Happy Independence Day)!
#MalaysianIndependenceDay#HariMerdeka
Ansh Labs announces the availability of a proprietary new web-based nomogram for use with the MenoCheck picoAMH immunoassay. First ever FDA-cleared, MenoCheck is designed to help physicians assess a woman’s menopausal status by measuring ultra-low levels of AMH.
#AMH#Menopause
Today is an auspicious day celebrated by Muslims around the world as the advent of the Islamic New Year. We wish everyone a new year full of peace, happiness and health. Have a blessed Muharram and Happy Islamic New Year!
#HappyMuharram#IslamicNewYear1443
The Dried Blood Spot technology has recently started to become popular for more routine tests as newer immunoassays have been developed that are optimized for DBS samples and have the sensitivities to detect low values. https://t.co/u9DUneHAyW
#driedbloodspot#ELISA#immunoassay
What is menopause, and why is it important to know this? Read the article below to know what causes menopause, the potential effects during menopausal transition, as well as the benefits of getting early treatments.
#menopause#PCOS#perimenopause#amh#fertility#MenoCheck
Low-end detection of AMH is important in many research applications. With over 50 scientific publications of our picoAMH immunoassay, our kits are known to be some of the most accurate assays on the market.
https://t.co/Wu9F3mDXjq
#AMH#ELISA#oncology#menopause#PCOS
Ever wonder why Ansh Labs developed a certain kit? View our list of assay kits as well as it's research areas and/ or emerging applications!
(NOTE: For Research Use Only unless otherwise stated in the product’s IFU)
#assaykits#immunoassays#RUO
A new test from Ansh Labs, the PCOCheck AMH ELISA, uses a two-sided linear epitope antibody that is specifically designed to avoid antibody binding at mutation sites as well as detect the various PCOS phenotypes. Read more here:
https://t.co/poJx4FcAoz
#immunoassay#pcos#amh
This study unravels strong link between Activin/Follistatin-axis and COVID-19 mortality and introduces FACT-CLINYCoD, a novel pathophysiology-based tool that allows dynamic prediction of disease outcome, supporting clinical decision making.
View our PDF:
https://t.co/ZgK0pEQJRM